- CA$917.30m
- CA$1.80bn
- CA$3.32bn
- 34
- 87
- 43
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,876 | 2,184 | 3,289 | 4,584 | 3,316 |
Cost of Revenue | |||||
Gross Profit | 147 | 601 | 1,341 | 1,202 | 157 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,005 | 1,781 | 2,211 | 3,724 | 3,626 |
Operating Profit | -129 | 402 | 1,078 | 860 | -310 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -138 | 370 | 1,089 | 815 | -358 |
Provision for Income Taxes | |||||
Net Income After Taxes | -104 | 280 | 819 | 598 | -267 |
Net Income Before Extraordinary Items | |||||
Net Income | -104 | 280 | 819 | 598 | -267 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -104 | 280 | 819 | 598 | -267 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.924 | 4.39 | 13 | 10.9 | -3.69 |
Special Dividends per Share |